Tag: CLINICAL TRIALS
-
TEDCO Invests $500,000 in Irazú Oncology to Advance Cancer Therapies
TEDCO has invested $500,000 in Irazú Oncology through its LSIF to enhance cancer therapies. CEO Jeff Strovel praised TEDCO’s role in advancing their platform. Operating from the University of Maryland BioPark, Irazú focuses on innovative cancer immunotherapy through unique technology. TEDCO seeks to support promising life sciences ventures, reinforcing Maryland’s leadership in the sector. TEDCO,…
-
Piramal Pharma Set to Enhance Injectables Portfolio for Critical Care Growth
– According to Nandini Piramal, Piramal Pharma expands its injectables portfolio. – Key new products include Chlorpromazine Hydrochloride and Edaravone for ALS. – The complex hospital generics business grew 14%, driven largely by inhalation anaesthetics. – Reports indicate that the CDMO division experienced an 18% growth in FY25 first nine months. Key Highlights – According…